Annual report pursuant to Section 13 and 15(d)

CONSOLIDATED STATEMENTS OF CHANGES IN CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' EQUITY

v3.24.2.u1
CONSOLIDATED STATEMENTS OF CHANGES IN CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' EQUITY - USD ($)
Preferred Stock [Member]
Common Stock [Member]
Additional Paid-in Capital [Member]
Treasury Stock, Common [Member]
Retained Earnings [Member]
AOCI Attributable to Parent [Member]
Total
Beginning balance, value at Apr. 30, 2022 $ 0 $ 2,072 $ 201,582,107 $ 0 $ (111,648,656) $ (15,757) $ 89,919,766
Beginning balance, shares at Apr. 30, 2022 0 20,721,047   0      
Stock issued for compensation 7,334 7,334
Stock issued for services 2,278 2,278
Stock issued for services, shares   1,002          
Stock issued for warrant exercise $ 88 792 880
Stock issued for warrant exercise, shares   880,000          
Stock-based compensation options 638,072 638,072
Reverse stock split adjustment
Reverse stock split adjustment, shares   29          
Gain on de-consolidation of subsidiary 5,876 5,876
Foreign currency translation adjustment (7,246) (7,246)
Net income (4,315,993) (4,315,993)
Repurchase of common stock $ (13,560,623) (13,560,623)
Repurchase of common stock, shares       (4,808,098)      
Ending balance, value at Apr. 30, 2023 $ 0 $ 2,160 202,230,583 $ (13,560,623) (115,958,773) (23,003) 72,690,344
Ending balance, shares at Apr. 30, 2023 0 21,602,078   (4,808,098)      
Stock issued for warrant exercise $ 7 63 70
Stock issued for warrant exercise, shares   70,000          
Stock-based compensation options 674,693 674,693
Series B preferred stock redeemed $ (13,999,302)
Series B preferred stock redeemed, shares (14,521)            
Series B preferred stock subject to redemption $ (5,940,278)            
Series B preferred stock subject to redemption, shares (5,833)            
Series B preferred stock dividends (2,517,645) (2,517,645)
Preferred stock accretion 15,053,521 (15,053,521) (15,053,521)
Issuance of Series B Preferred Stock, net of discounts and issuance costs of $18,246,925 $ 16,753,075
Issuance of Series B Preferred Stock, net of discounts and issuance costs, shares 35,000            
Foreign currency translation adjustment (508) (508)
Net income 333,763 333,763
Repurchase of common stock $ (28,479,593) (28,479,593)
Repurchase of common stock, shares       (8,826,356)      
Ending balance, value at Apr. 30, 2024 $ 11,867,016 $ 2,167 $ 185,334,173 $ (42,040,216) $ (115,625,010) $ (23,511) $ 27,647,603
Ending balance, shares at Apr. 30, 2024 14,646 21,672,078   (13,634,454)